Table 2.
Regimen | MSS (n=147) | MSI (n=6) |
---|---|---|
FOLFIRI/cetuximab | 16 (10.9) | 2 (33.3) |
FOLFOX/cetuximab | 13 (8.8) | |
XELOX/cetuximab | 7 (4.8) | |
XELRI/cetuximab | 7 (4.8) | |
Irinotecan/cetuximab | 83 (56.5) | 3 (50.0) |
Cetuximab | 21 (14.3) | 1 (16.7) |
Regimen | MSS (n=147) | MSI (n=6) |
---|---|---|
FOLFIRI/cetuximab | 16 (10.9) | 2 (33.3) |
FOLFOX/cetuximab | 13 (8.8) | |
XELOX/cetuximab | 7 (4.8) | |
XELRI/cetuximab | 7 (4.8) | |
Irinotecan/cetuximab | 83 (56.5) | 3 (50.0) |
Cetuximab | 21 (14.3) | 1 (16.7) |